|
John R. Daniels M.D. has served as a director on the Endocare board since February 2004. Dr. Daniels has taken a number of medical ideas and technologies from the laboratories of the academic world through the business planning stage to the successful launch and growth of corporations based on those ideas. He is currently Chairman of Balance Pharmaceuticals, a company he founded in 1992. From 1997 until 2002, Dr. Daniels was Chairman of Cohesion Technologies, which was sold to Angiotech Pharmaceuticals in January 2003. From 1985 to 1989, he was the Chief Executive Officer of Target Therapeutics. Dr. Daniels was a founder of Collagen Corporation in 1975 serving as vice-president for scientific and technical affairs from 1978-79 and continuing as a Director through 1998. On the academic side, Dr. Daniels has been an Associate Professor of Radiology (Courtesy) at the University of Southern California (USC) School of Medicine, since 1990 and he has been an Associate Professor of Medicine, Division of Oncology at the USC School of Medicine since 1979. From 1970 to 1979, Dr. Daniels taught in the Division of Oncology at the Stanford University School of Medicine as an instructor, assistant professor and clinical associate professor. He served his internship and residency in the Department of Medicine at the Stanford University School of Medicine. From 1966 to 1969, Dr. Daniels was a Research Associate in the National Institute of Dental Research at the National Institutes of Health. Dr. Daniels received his Bachelor of Arts from the Stanford University Department of Biology and his Doctor of Medicine from the Stanford University School of Medicine. | 